News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
585 Results
Type
Article (69)
Company Profile (1)
Press Release (515)
Section
Business (203)
Deals (43)
Drug Development (73)
FDA (26)
Job Trends (3)
News (305)
Policy (26)
Tag
Adcomms (1)
Alliances (43)
ALS (1)
Alzheimer's disease (1)
Approvals (26)
Autoimmune disease (11)
Best Places to Work (3)
Biotechnology (1)
Breast cancer (1)
Cancer (4)
Cardiovascular disease (1)
Cell therapy (2)
Clinical research (67)
Collaboration (5)
COVID-19 (1)
C-suite (5)
Data (17)
Diagnostics (3)
Duchenne muscular dystrophy (2)
Earnings (115)
Events (125)
Executive appointments (5)
FDA (36)
Frontotemporal dementia (1)
Funding (3)
GLP-1 (3)
Government (4)
Guidances (4)
Healthcare (100)
Immunology and inflammation (11)
Infectious disease (1)
IPO (33)
Legal (1)
Lung cancer (1)
Manufacturing (2)
Medical device (2)
Medtech (2)
Mergers & acquisitions (10)
Metabolic disorders (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (1)
Neuroscience (6)
NextGen: Class of 2026 (4)
Non-profit (1)
Obesity (1)
Ovarian cancer (1)
Pancreatic cancer (1)
Parkinson's disease (1)
People (43)
Phase 1 (16)
Phase 2 (25)
Phase 3 (37)
Pipeline (18)
Policy (1)
Postmarket research (1)
Preclinical (6)
Rare diseases (5)
Real estate (1)
Regulatory (39)
Research institute (2)
Series A (2)
Series B (1)
Startups (3)
Tariffs (1)
Vaccines (1)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (63)
2026 (34)
2025 (63)
2024 (74)
2023 (82)
2022 (83)
2021 (70)
2020 (41)
2019 (32)
2018 (11)
2017 (35)
2016 (16)
2015 (13)
2014 (7)
2013 (10)
2012 (6)
2011 (5)
2010 (1)
Location
Asia (21)
California (14)
Canada (2)
China (9)
Colorado (1)
Europe (291)
Japan (1)
Massachusetts (18)
New Jersey (2)
New York (4)
North Carolina (2)
Northern California (8)
Southern California (7)
United States (40)
585 Results for "argenx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
argenx to Host Autoimmune Myositis R&D Webinar
June 23, 2026
·
1 min read
Press Releases
argenx to Present at Upcoming June 2026 Investor Conferences
May 27, 2026
·
1 min read
Press Releases
argenx to Host Myositis R&D Webinar on June 23, 2026
May 28, 2026
·
1 min read
Press Releases
argenx to Present at BofA Securities 2026 Health Care Conference
May 7, 2026
·
1 min read
Press Releases
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
·
16 min read
Regulatory
FDA Mulls ‘Regulatory Action’ on Argenx’s Vyvgart Hytrulo Over Severe Safety Concerns
The safety update for Vyvgart rattled argenx’s shares on Monday, a reaction that analysts at William Blair said was “overdone.”
July 2, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate
The FDA is looking at a slew of label expansions this month, including one that could open up home-based treatments for Alzheimer’s disease.
May 4, 2026
·
4 min read
·
Tristan Manalac
Press Releases
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
April 30, 2026
·
1 min read
Press Releases
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
June 3, 2026
·
14 min read
Press Releases
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
May 7, 2026
·
3 min read
1 of 59
Next
